Literature DB >> 8430802

Interleukin-1 beta modulation of norepinephrine release from rat myenteric nerves.

S Hurst1, S M Collins.   

Abstract

We examined the ability of human recombinant interleukin-1 beta (hrIL-1 beta) to alter the release of [3H]norepinephrine ([3H]NE) by KCl or electrical field stimulation in longitudinal muscle-myenteric plexus of rat intestine. The cytokine had no immediate effect on either the basal or evoked release of [3H]NE. However, hrIL-1 beta caused a biphasic time-dependent suppression of evoked [3H]NE release that was delayed in onset. IL-1 beta also stimulated the cycloheximide-sensitive uptake of [35S] methionine uptake by the tissue. The initial suppression of [3H]NE release was observed after 30 min and could not be inhibited by cycloheximide. A delayed peak was observed after 120 min and was inhibited by cycloheximide. The effect of IL-1 beta was maximal at 10 ng/ml and could be prevented by a neutralizing anti-IL-1 beta antibody or by preincubating the tissue with an IL-1-receptor antagonist. These results indicate that IL-1 beta suppresses [3H]NE release from rat myenteric plexus by two mechanisms, one of which is independent of protein synthesis and the other of which is mediated by endogenous IL-1.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8430802     DOI: 10.1152/ajpgi.1993.264.1.G30

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  17 in total

1.  IL-1beta and IL-6 excite neurons and suppress nicotinic and noradrenergic neurotransmission in guinea pig enteric nervous system.

Authors:  Y Xia; H Z Hu; S Liu; J Ren; D H Zafirov; J D Wood
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

2.  Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjögren's syndrome.

Authors:  D Zoukhri; C L Kublin
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-04       Impact factor: 4.799

3.  c-Jun NH2-terminal kinase mediates interleukin-1beta-induced inhibition of lacrimal gland secretion.

Authors:  Driss Zoukhri; Elizabeth Macari; Sun H Choi; Claire L Kublin
Journal:  J Neurochem       Date:  2005-11-21       Impact factor: 5.372

Review 4.  Intestinal dysmotility in inflammatory bowel disease: mechanisms of the reduced activity of smooth muscle contraction.

Authors:  Hiroshi Ozaki; Masatoshi Hori; Kazuya Kinoshita; Takashi Ohama
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

5.  Role of proinflammatory cytokines in the impaired lacrimation associated with autoimmune xerophthalmia.

Authors:  Driss Zoukhri; Robin R Hodges; Dosek Byon; Claire Larkin Kublin
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-05       Impact factor: 4.799

6.  Key role of the sympathetic microenvironment for the interplay of tumour necrosis factor and interleukin 6 in normal but not in inflamed mouse colon mucosa.

Authors:  R H Straub; K Stebner; P Härle; F Kees; W Falk; J Schölmerich
Journal:  Gut       Date:  2005-04-21       Impact factor: 23.059

Review 7.  Divergent neuroendocrine responses to localized and systemic inflammation.

Authors:  Mark K Lukewich; Richard C Rogers; Alan E Lomax
Journal:  Semin Immunol       Date:  2014-01-31       Impact factor: 11.130

8.  Generalized loss of inhibitory innervation reverses serotonergic inhibition into excitation in a rabbit model of TNBS-colitis.

Authors:  Inge Depoortere; Theo Thijs; Theo L Peeters
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

9.  Immunomodulatory effects of inhaled carbon monoxide on rat syngeneic small bowel graft motility.

Authors:  A Nakao; B A Moore; N Murase; F Liu; B S Zuckerbraun; F H Bach; A M K Choi; M A Nalesnik; L E Otterbein; A J Bauer
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

10.  Interleukin-1 beta and tumor necrosis factor-alpha inhibit the release of [3H]-noradrenaline from mice isolated atria.

Authors:  S Foucart; C Abadie
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.